Cargando…
Melanocortin Peptides: Potential Targets in Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease resulting in loss of self-tolerance with multiple organs, such as the kidney, skin, joints, and the central nervous system (CNS), being targeted. Numerous immunosuppressant therapies are currently being used for the treatment of SLE...
Autores principales: | Loram, Lisa Carole, Culp, Melissa Elizabeth, Connolly-Strong, Erin Corey, Sturgill-Koszycki, Sheila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312383/ https://www.ncbi.nlm.nih.gov/pubmed/25323206 http://dx.doi.org/10.1007/s10753-014-0029-5 |
Ejemplares similares
-
Legionella pneumophila Replication Vacuoles Mature into Acidic, Endocytic Organelles
por: Sturgill-Koszycki, Sheila, et al.
Publicado: (2000) -
Clinical and immunologic studies in identical twins discordant for systemic lupus erythematosus()
por: Brunner, Carolyn M., et al.
Publicado: (1973) -
Melanocortin Peptide Therapy for the Treatment of Arthritic Pathologies
por: Getting, S. J., et al.
Publicado: (2009) -
Endoplasmic Reticulum Stress in Systemic Lupus Erythematosus and Lupus Nephritis: Potential Therapeutic Target
por: Li, Hui-Yuan, et al.
Publicado: (2023) -
Anakinra for Recurrent Fevers in Systemic Lupus Erythematosus
por: Dein, Eric, et al.
Publicado: (2018)